Insulin Glulisine

Drug Index

Insulin glulisine is a rapid-acting insulin analogue that differs from human insulin in that the amino acid asparagine at position B3 is replaced by lysine and the lysine in position B29 is replaced by glutamic acid.[4] It was developed by Sanofi-Aventis and is sold under the trade name Apidra.[5] When injected subcutaneously, it appears in the blood earlier than human insulin.[6] When used as a meal time insulin, the dose is to be administered ...

NDC Database

Apidra 100 [iu]/Ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC ## Package Codes: 0088-2500-33, 0088-2500-34 ## Active Ingredients: Insulin Glulisine